ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,728,169, issued on Sept. 8, was assigned to THE SCRIPPS RESEARCH INSTITUTE (La Jolla, Calif.).

"Immune cell receptor antibodies conjugated to high affinity siglec-ligands" was invented by James C. Paulson (Del Mar, Calif.), Maidul Islam (San Diego), Fabian Pfrengle (Klosterneuburg, Austria), Matthew Macauley (Edmonton, Canada), Shiteng Duan (San Diego) and Britni Arlian (Spring Valley, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Described herein are Siglec ligand-antibody conjugates and compositions thereof that are useful for suppressing unwanted immune responses such as allergies and anaphylaxis."

The patent was filed on Oct. 28, 2020, unde...